Share-based Payment Arrangement, Expense of Kronos Bio, Inc. from 31 Dec 2018 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kronos Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2018 to 31 Mar 2025.
  • Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $604,000, a 92% decline year-over-year.
  • Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $7,035,000, a 73% decline year-over-year.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $14,137,000, a 43% decline from 2023.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $24,982,000, a 20% decline from 2022.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31,145,000, a 19% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Kronos Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $7,035,000 $604,000 -$7,102,000 -92% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $14,137,000 $2,198,000 -$2,975,000 -58% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q3 2024 $17,112,000 $2,030,000 -$4,266,000 -68% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $21,378,000 $2,203,000 -$4,703,000 -68% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $26,081,000 $7,706,000 +$1,099,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $24,982,000 $5,173,000 -$2,516,000 -33% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $27,498,000 $6,296,000 -$1,165,000 -16% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $28,663,000 $6,906,000 -$1,301,000 -16% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $29,964,000 $6,607,000 -$1,181,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $31,145,000 $7,689,000 +$285,000 +3.8% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $30,860,000 $7,461,000 +$324,000 +4.5% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $30,536,000 $8,207,000 +$1,775,000 +28% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $28,761,000 $7,788,000 +$2,550,000 +49% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $26,211,000 $7,404,000 +$5,386,000 +267% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $20,825,000 $7,137,000 +$5,883,000 +469% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $14,942,000 $6,432,000 +$6,139,000 +2095% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $8,803,000 $5,238,000 +$5,050,000 +2686% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $3,753,000 $2,018,000 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $1,254,000 +$1,231,000 +5352% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $293,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $188,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $23,000 01 Jul 2019 30 Sep 2019 10-Q 18 Nov 2020 2020 Q3

Kronos Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $14,137,000 -$10,845,000 -43% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 $24,982,000 -$6,163,000 -20% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $31,145,000 +$4,934,000 +19% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $26,211,000 +$22,458,000 +598% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $3,753,000 +$3,640,000 +3221% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $113,000 +$83,000 +277% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $30,000 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.